Inbios Intl., Inc.

Inbios Intl., Inc. — FDA 510(k) Submissions

Inbios Intl., Inc. has submitted 6 FDA 510(k) premarket notifications since 1999, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Dengue Serological Reagents, Glucose Oxidase, Glucose, Reagent, Leishmanii Serological, Elisa, Antibody, West Nile Virus, System, Test, Human Chorionic Gonadotropin . Use the specialty filter in the sidebar to narrow results.